http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0d68e73948b6203e6cce0d864bee0fc

Outgoing Links

Predicate Object
family-name Lainchbury
name Michael Lainchbury
given-name Michael
organization-name Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK
Charles River Laboratories, 8-9 Spire Green, Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom
Authors' Affiliations: 1Division of Cancer Therapeutics, 2Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton; and 3Sareum Ltd, Cambridge, United Kingdom
Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
Argenta, Early Discovery Charles River, 7/9 Spire Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom
Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG U. K.

Incoming Links

Predicate Subject
creator http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5985487
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3905558
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25805980
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3389139
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9327009
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16319178
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34679223
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16317848
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23048980
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9411236

Total number of triples: 19.